| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.736 | 0.023 | 0.756 | Transcription factor inhibitor | 0.756 0.02 DBMET01012 | DBMET01012 | |
| 0.634 | 0.013 | 0.634 | Aryl hydrocarbon receptor agonist | 0.599 0.015 DBMET01012 0.179 0.115 DBMET01013 | ||
| 0.583 | 0.063 | 0.641 | DNA polymerase beta inhibitor | 0.641 0.05 DBMET01012 | DBMET01012 | |
| 0.516 | 0.036 | 0.74 | Antibacterial | 0.539 0.031 DBMET01012 0.74 0.006 DBMET01013 | DBMET01013 | |
| 0.547 | 0.069 | 0.625 | DNA directed DNA polymerase inhibitor | 0.625 0.049 DBMET01012 0.327 0.149 DBMET01013 | DBMET01012 | |
| 0.495 | 0.034 | 0.506 | 5 Hydroxytryptamine release inhibitor | 0.338 0.126 DBMET01012 0.506 0.03 DBMET01013 | DBMET01013 | |
| 0.463 | 0.004 | 0.581 | MAP kinase 8 inhibitor | 0.581 0.004 DBMET01012 0.154 0.028 DBMET01013 | DBMET01012 | |
| 0.47 | 0.033 | 0.602 | Streptokinase A inhibitor | 0.602 0.016 DBMET01012 | DBMET01012 | |
| 0.466 | 0.036 | 0.529 | Thioredoxin glutathione reductase inhibitor | 0.529 0.024 DBMET01012 | DBMET01012 | |
| 0.462 | 0.035 | 0.491 | Calpain 2 inhibitor | 0.491 0.027 DBMET01012 | DBMET01012 | |
| 0.409 | 0.004 | 0.409 | Antibacterial (Helicobacter pylori) | 0.306 0.006 DBMET01012 0.203 0.021 DBMET01013 | ||
| 0.403 | 0.037 | 0.502 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.502 0.019 DBMET01012 | DBMET01012 | |
| 0.445 | 0.086 | 0.445 | Caspase 9 stimulant | 0.346 0.148 DBMET01012 0.378 0.125 DBMET01013 | ||
| 0.349 | 0.017 | 0.481 | DNA methylase inhibitor | 0.341 0.018 DBMET01012 0.481 0.006 DBMET01013 | DBMET01013 | |
| 0.339 | 0.016 | 0.459 | DNA methyltransferase I inhibitor | 0.337 0.016 DBMET01012 0.459 0.005 DBMET01013 | DBMET01013 | |
| 0.285 | 0.016 | 0.285 | Nitric-oxide synthase stimulant | 0.239 0.041 DBMET01012 0.254 0.03 DBMET01013 | ||
| 0.279 | 0.022 | 0.301 | Thiol protease inhibitor | 0.301 0.019 DBMET01012 0.123 0.11 DBMET01013 | DBMET01012 | |
| 0.259 | 0.004 | 0.259 | Glutathione S-transferase inhibitor | 0.241 0.004 DBMET01012 0.123 0.021 DBMET01013 | ||
| 0.274 | 0.019 | 0.428 | Heat shock protein 90 alpha antagonist | 0.428 0.005 DBMET01012 | DBMET01012 | |
| 0.299 | 0.075 | 0.348 | Nootropic | 0.348 0.054 DBMET01012 | DBMET01012 | |
| 0.332 | 0.122 | 0.332 | Beta lactamase inhibitor | 0.285 0.141 DBMET01012 | ||
| 0.215 | 0.015 | 0.227 | CF transmembrane conductance regulator agonist | 0.227 0.011 DBMET01012 0.147 0.081 DBMET01013 | DBMET01012 | |
| 0.214 | 0.028 | 0.322 | Alkaline phosphatase inhibitor | 0.311 0.01 DBMET01012 0.322 0.009 DBMET01013 | DBMET01013 | |
| 0.247 | 0.068 | 0.257 | Calpain inhibitor | 0.257 0.058 DBMET01012 | DBMET01012 | |
| 0.211 | 0.033 | 0.334 | Heat shock protein 90 antagonist | 0.334 0.006 DBMET01012 0.128 0.101 DBMET01013 | DBMET01012 | |
| 0.205 | 0.028 | 0.42 | Cell wall synthesis inhibitor | 0.225 0.022 DBMET01012 0.42 0.005 DBMET01013 | DBMET01013 | |
| 0.188 | 0.026 | 0.211 | Interleukin 4 antagonist | 0.211 0.019 DBMET01012 0.174 0.032 DBMET01013 | DBMET01012 | |
| 0.209 | 0.048 | 0.209 | Tumour necrosis factor antagonist | 0.173 0.073 DBMET01012 | ||
| 0.231 | 0.076 | 0.385 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.385 0.028 DBMET01012 | DBMET01012 | |
| 0.286 | 0.131 | 0.404 | Histamine release inhibitor | 0.221 0.179 DBMET01012 0.404 0.074 DBMET01013 | DBMET01013 | |
| 0.222 | 0.07 | 0.39 | Pyruvate kinase inhibitor | 0.39 0.022 DBMET01012 | DBMET01012 | |
| 0.161 | 0.025 | 0.179 | Sphingosine 1-phosphate receptor 4 antagonist | 0.179 0.015 DBMET01012 | DBMET01012 | |
| 0.219 | 0.084 | 0.493 | Free radical scavenger | 0.271 0.06 DBMET01012 0.493 0.017 DBMET01013 | DBMET01013 | |
| 0.229 | 0.094 | 0.248 | DNA damaging | 0.21 0.108 DBMET01012 0.248 0.081 DBMET01013 | DBMET01013 | |
| 0.219 | 0.088 | 0.369 | Dyrk kinase inhibitor | 0.369 0.033 DBMET01012 | DBMET01012 | |
| 0.158 | 0.035 | 0.279 | MAP kinase 9 inhibitor | 0.279 0.014 DBMET01012 | DBMET01012 | |
| 0.196 | 0.076 | 0.196 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.175 0.099 DBMET01012 | ||
| 0.181 | 0.066 | 0.299 | Mcl-1 antagonist | 0.299 0.023 DBMET01012 | DBMET01012 | |
| 0.156 | 0.054 | 0.156 | Calcium channel blocker | |||
| 0.136 | 0.037 | 0.153 | CDK3/cyclin E inhibitor | 0.153 0.025 DBMET01012 | DBMET01012 | |
| 0.107 | 0.009 | 0.279 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.279 0.003 DBMET01012 | DBMET01012 | |
| 0.23 | 0.132 | 0.25 | Caspase 3 stimulant | 0.189 0.187 DBMET01012 0.25 0.112 DBMET01013 | DBMET01013 | |
| 0.1 | 0.004 | 0.1 | Methionyl aminopeptidase 1 inhibitor | 0.054 0.005 DBMET01012 | ||
| 0.123 | 0.028 | 0.161 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.161 0.016 DBMET01012 | DBMET01012 | |
| 0.105 | 0.016 | 0.15 | DNA gyrase inhibitor | 0.137 0.01 DBMET01012 0.15 0.008 DBMET01013 | DBMET01013 | |
| 0.208 | 0.124 | 0.209 | Transcription factor STAT3 inhibitor | 0.209 0.122 DBMET01012 | DBMET01012 | |
| 0.09 | 0.016 | 0.09 | Transcription factor AP-1 inhibitor | 0.07 0.03 DBMET01012 0.068 0.033 DBMET01013 | ||
| 0.133 | 0.069 | 0.133 | Toll-Like receptor antagonist | 0.11 0.102 DBMET01012 | ||
| 0.136 | 0.072 | 0.136 | Toll-Like receptor 9 antagonist | |||
| 0.248 | 0.189 | 0.657 | Alpha-glucosidase inhibitor | 0.406 0.112 DBMET01012 0.657 0.042 DBMET01013 | DBMET01013 | |
| 0.101 | 0.047 | 0.101 | Thioredoxin inhibitor | 0.1 0.048 DBMET01013 | ||
| 0.144 | 0.091 | 0.188 | Melanin inhibitor | 0.143 0.092 DBMET01012 0.188 0.047 DBMET01013 | DBMET01013 | |
| 0.114 | 0.064 | 0.114 | Calcium channel (voltage-sensitive) blocker | |||
| 0.095 | 0.047 | 0.109 | Interleukin 5 antagonist | 0.109 0.032 DBMET01012 0.105 0.036 DBMET01013 | DBMET01012 | |
| 0.075 | 0.029 | 0.133 | Neuraminidase (influenza) inhibitor | 0.098 0.017 DBMET01012 0.133 0.009 DBMET01013 | DBMET01013 | |
| 0.195 | 0.157 | 0.336 | 12-Lipoxygenase inhibitor | 0.336 0.062 DBMET01012 | DBMET01012 | |
| 0.04 | 0.009 | 0.04 | Elastase 3B inhibitor | |||
| 0.04 | 0.009 | 0.04 | Elastase 3A inhibitor | |||
| 0.04 | 0.009 | 0.04 | Elastase 2B inhibitor | |||
| 0.108 | 0.078 | 0.114 | Caspase 3 inhibitor | 0.114 0.068 DBMET01012 | DBMET01012 | |
| 0.083 | 0.055 | 0.092 | T cell inhibitor | 0.092 0.034 DBMET01013 | DBMET01013 | |
| 0.072 | 0.044 | 0.072 | Elastase 1 inhibitor | |||
| 0.245 | 0.22 | 0.442 | Apoptosis agonist | 0.442 0.094 DBMET01013 | DBMET01013 | |
| 0.073 | 0.051 | 0.125 | Histone deacetylase SIRT1 stimulant | 0.101 0.027 DBMET01012 0.125 0.016 DBMET01013 | DBMET01013 | |
| 0.073 | 0.051 | 0.125 | Histone deacetylase stimulant | 0.101 0.027 DBMET01012 0.125 0.016 DBMET01013 | DBMET01013 | |
| 0.07 | 0.048 | 0.155 | CDK2/cyclin E2 inhibitor | 0.155 0.016 DBMET01012 | DBMET01012 | |
| 0.042 | 0.02 | 0.069 | DNA gyrase subunit B inhibitor | 0.056 0.01 DBMET01012 0.069 0.007 DBMET01013 | DBMET01013 | |
| 0.063 | 0.044 | 0.063 | Nitric oxide donor | |||
| 0.074 | 0.057 | 0.074 | Keratolytic | |||
| 0.108 | 0.092 | 0.163 | Cyclooxygenase 3 inhibitor | 0.163 0.038 DBMET01013 | DBMET01013 | |
| 0.126 | 0.111 | 0.126 | Growth hormone agonist | |||
| 0.191 | 0.178 | 0.428 | Transcription factor NF kappa B inhibitor | 0.428 0.057 DBMET01013 | DBMET01013 | |
| 0.162 | 0.151 | 0.495 | Antioxidant | 0.198 0.115 DBMET01012 0.495 0.021 DBMET01013 | DBMET01013 | |
| 0.047 | 0.035 | 0.047 | Carnitine palmitoyltransferase 1B inhibitor | 0.047 0.034 DBMET01012 | ||
| 0.179 | 0.169 | 0.197 | Transcription factor STAT inhibitor | 0.197 0.143 DBMET01012 | DBMET01012 | |
| 0.164 | 0.154 | 0.193 | Interleukin agonist | 0.193 0.127 DBMET01013 | DBMET01013 | |
| 0.127 | 0.119 | 0.198 | Dual specificity phosphatase 3 inhibitor | 0.198 0.062 DBMET01012 | DBMET01012 | |
| 0.12 | 0.116 | 0.151 | CC chemokine 6 receptor antagonist | 0.135 0.052 DBMET01012 0.151 0.021 DBMET01013 | DBMET01013 | |
| 0.088 | 0.084 | 0.128 | Mediator release inhibitor | 0.128 0.041 DBMET01013 | DBMET01013 | |
| 0.096 | 0.093 | 0.193 | Alkylator | 0.193 0.028 DBMET01013 | DBMET01013 | |
| 0.008 | 0.006 | 0.008 | Free fatty acid receptor 2 antagonist | 0.008 0.005 DBMET01012 | ||
| 0.06 | 0.06 | 0.09 | Potassium channel large-conductance Ca-activated activator | 0.09 0.029 DBMET01012 | DBMET01012 | |
| 0.077 | 0.079 | 0.131 | D-Ala-D-Ala ligase inhibitor | 0.131 0.009 DBMET01012 | DBMET01012 | |
| 0.05 | 0.058 | 0.099 | Neuraminidase inhibitor | 0.067 0.036 DBMET01012 0.099 0.016 DBMET01013 | DBMET01013 | |
| 0.059 | 0.068 | 0.083 | MAP kinase kinase 8 inhibitor | 0.083 0.032 DBMET01012 | DBMET01012 | |
| 0.083 | 0.093 | 0.142 | Cyclin-dependent kinase 5 inhibitor | 0.142 0.045 DBMET01012 | DBMET01012 | |
| 0.123 | 0.137 | 0.131 | Amyloid beta precursor protein antagonist | 0.131 0.125 DBMET01012 | DBMET01012 | |
| 0.166 | 0.182 | 0.177 | Lipoxygenase inhibitor | 0.177 0.167 DBMET01012 | DBMET01012 | |
| 0.092 | 0.109 | 0.1 | Calcium channel N-type blocker | 0.1 0.095 DBMET01012 | DBMET01012 | |
| 0.077 | 0.101 | 0.166 | Xanthine oxidase inhibitor | 0.087 0.076 DBMET01012 0.166 0.029 DBMET01013 | DBMET01013 | |
| 0.027 | 0.056 | 0.086 | CDK5/p25 inhibitor | 0.086 0.008 DBMET01012 | DBMET01012 | |
| 0.021 | 0.054 | 0.03 | Catechol O-methyltransferase inhibitor | 0.03 0.027 DBMET01012 | DBMET01012 | |
| 0.072 | 0.106 | 0.183 | UDP-glucose 4-epimerase inhibitor | 0.104 0.057 DBMET01012 0.183 0.021 DBMET01013 | DBMET01013 | |
| 0.038 | 0.072 | 0.06 | CXC chemokine 1 receptor antagonist | 0.06 0.022 DBMET01012 | DBMET01012 | |
| 0.188 | 0.223 | 0.215 | GABA C receptor rho-3 antagonist | 0.215 0.189 DBMET01012 | DBMET01012 | |
| 0.029 | 0.073 | 0.055 | Aldose reductase inhibitor | 0.055 0.035 DBMET01013 | DBMET01013 | |
| 0.11 | 0.158 | 0.169 | Dual specificity phosphatase inhibitor | 0.169 0.076 DBMET01012 | DBMET01012 | |
| 0.065 | 0.114 | 0.13 | Triose-phosphate isomerase inhibitor | 0.13 0.027 DBMET01013 | DBMET01013 | |
| 0.037 | 0.093 | 0.056 | Cyclin H inhibitor | 0.056 0.045 DBMET01012 | DBMET01012 | |
| 0.148 | 0.204 | 0.264 | Prostaglandin dehydrogenase inhibitor | 0.264 0.12 DBMET01012 | DBMET01012 | |
| 0.076 | 0.136 | 0.176 | Glycogen synthase kinase-3 alpha inhibitor | 0.176 0.05 DBMET01012 | DBMET01012 | |
| 0.097 | 0.156 | 0.197 | Mannose-6-phosphate isomerase inhibitor | 0.197 0.032 DBMET01012 0.182 0.041 DBMET01013 | DBMET01012 | |
| 0.023 | 0.083 | 0.062 | Cyclin E1 inhibitor | 0.062 0.032 DBMET01012 | DBMET01012 | |
| 0.108 | 0.17 | 0.167 | Interferon gamma antagonist | 0.167 0.059 DBMET01013 | DBMET01013 | |
| 0.099 | 0.165 | 0.315 | NOS3 expression enhancer | 0.141 0.082 DBMET01012 0.315 0.016 DBMET01013 | DBMET01013 | |
| 0.058 | 0.129 | 0.093 | Potassium channel activator | 0.093 0.057 DBMET01012 | DBMET01012 | |
| 0.023 | 0.096 | 0.07 | Cyclin E inhibitor | 0.07 0.036 DBMET01012 | DBMET01012 | |
| 0.051 | 0.124 | 0.173 | Monophenol monooxygenase inhibitor | 0.173 0.04 DBMET01013 | DBMET01013 | |
| 0.048 | 0.126 | 0.101 | Potassium channel (Ca-activated) activator | 0.101 0.054 DBMET01012 | DBMET01012 | |
| 0.037 | 0.116 | 0.124 | Histidine decarboxylase inhibitor | 0.124 0.024 DBMET01012 | DBMET01012 | |
| 0.096 | 0.177 | 0.166 | Clk dual-specificity kinase inhibitor | 0.166 0.101 DBMET01012 | DBMET01012 | |
| 0.064 | 0.147 | 0.185 | M18 aspartyl aminopeptidase inhibitor | 0.185 0.038 DBMET01012 | DBMET01012 | |
| 0.194 | 0.284 | 0.284 | Calcium channel L-type activator | 0.284 0.171 DBMET01012 | DBMET01012 | |
| 0.059 | 0.156 | 0.112 | Transcription factor NF kappa B stimulant | 0.112 0.03 DBMET01013 | DBMET01013 | |
| 0.062 | 0.17 | 0.201 | Beta glucuronidase inhibitor | 0.104 0.064 DBMET01012 0.201 0.013 DBMET01013 | DBMET01013 | |
| 0.068 | 0.177 | 0.126 | DOPA decarboxylase inhibitor | 0.126 0.038 DBMET01012 | DBMET01012 | |
| 0.035 | 0.145 | 0.086 | MAO B inhibitor | 0.086 0.07 DBMET01012 | DBMET01012 | |
| 0.034 | 0.144 | 0.08 | Purinergic P2X1 antagonist | 0.08 0.025 DBMET01012 | DBMET01012 | |
| 0.065 | 0.182 | 0.11 | M17 leucyl aminopeptidase inhibitor | 0.11 0.088 DBMET01012 | DBMET01012 | |
| 0.112 | 0.23 | 0.14 | Neurotensin receptor agonist | 0.14 0.13 DBMET01012 | DBMET01012 | |
| 0.045 | 0.164 | 0.116 | Urease inhibitor | 0.116 0.049 DBMET01012 | DBMET01012 | |
| 0.074 | 0.204 | 0.11 | Protein kinase stimulant | 0.11 0.104 DBMET01013 | DBMET01013 | |
| 0.101 | 0.236 | 0.145 | Succinate dehydrogenase inhibitor | 0.145 0.122 DBMET01012 | DBMET01012 | |
| 0.027 | 0.163 | 0.086 | Heparanase inhibitor | 0.086 0.005 DBMET01013 | DBMET01013 | |
| 0.026 | 0.162 | 0.056 | Cyclin D1 inhibitor | 0.056 0.049 DBMET01012 | DBMET01012 | |
| 0.133 | 0.271 | 0.252 | Vasodilator, coronary | 0.252 0.132 DBMET01013 | DBMET01013 | |
| 0.025 | 0.168 | 0.054 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.054 0.047 DBMET01012 | DBMET01012 | |
| 0.028 | 0.171 | 0.078 | Porphobilinogen synthase inhibitor | 0.078 0.049 DBMET01012 | DBMET01012 | |
| 0.098 | 0.251 | 0.225 | ATPase inhibitor | 0.225 0.021 DBMET01013 | DBMET01013 | |
| 0.026 | 0.18 | 0.058 | Glucose-6-phosphate translocase inhibitor | 0.058 0.025 DBMET01013 | DBMET01013 | |
| 0.045 | 0.2 | 0.092 | Uric acid excretion stimulant | 0.092 0.062 DBMET01013 | DBMET01013 | |
| 0.054 | 0.212 | 0.172 | Lipid peroxidase inhibitor | 0.172 0.054 DBMET01013 | DBMET01013 | |
| 0.05 | 0.215 | 0.092 | Carbonic anhydrase III inhibitor | 0.092 0.072 DBMET01012 | DBMET01012 | |
| 0.053 | 0.227 | 0.127 | Alpha-N-acetylglucosaminidase inhibitor | 0.127 0.071 DBMET01013 | DBMET01013 | |
| 0.106 | 0.281 | 0.215 | Superoxide dismutase inhibitor | 0.215 0.102 DBMET01012 | DBMET01012 | |
| 0.075 | 0.258 | 0.289 | Platelet adhesion inhibitor | 0.289 0.037 DBMET01013 | DBMET01013 | |
| 0.124 | 0.311 | 0.221 | 15-Lipoxygenase inhibitor | 0.221 0.191 DBMET01012 | DBMET01012 | |
| 0.038 | 0.235 | 0.1 | ATPase (Vacuolar H+) inhibitor | 0.1 0.039 DBMET01013 | DBMET01013 | |
| 0.129 | 0.328 | 0.3 | Apoptosis antagonist | 0.3 0.085 DBMET01013 | DBMET01013 | |
| 0.034 | 0.239 | 0.1 | Expectorant | 0.1 0.069 DBMET01013 | DBMET01013 | |
| 0.049 | 0.262 | 0.127 | Toll-Like receptor 4 antagonist | 0.127 0.037 DBMET01013 | DBMET01013 | |
| 0.043 | 0.259 | 0.241 | Amylase inhibitor | 0.241 0.031 DBMET01013 | DBMET01013 | |
| 0.101 | 0.331 | 0.201 | Cholesterol antagonist | 0.201 0.164 DBMET01013 | DBMET01013 | |
| 0.054 | 0.291 | 0.113 | Peroxidase inhibitor | 0.113 0.108 DBMET01012 | DBMET01012 | |
| 0.112 | 0.351 | 0.355 | Peptidyltransferase inhibitor | 0.355 0.011 DBMET01013 | DBMET01013 | |
| 0.066 | 0.307 | 0.311 | Hepatoprotectant | 0.311 0.027 DBMET01013 | DBMET01013 | |
| 0.063 | 0.305 | 0.234 | Nitric oxide antagonist | 0.234 0.056 DBMET01013 | DBMET01013 | |
| 0.074 | 0.318 | 0.161 | Vasodilator | 0.161 0.142 DBMET01013 | DBMET01013 | |
| 0.084 | 0.336 | 0.483 | Hypoglycemic | 0.483 0.017 DBMET01013 | DBMET01013 | |
| 0.013 | 0.266 | 0.061 | Phosphofructokinase-1 inhibitor | 0.061 0.055 DBMET01013 | DBMET01013 | |
| 0.061 | 0.321 | 0.187 | Platelet antagonist | 0.187 0.112 DBMET01013 | DBMET01013 | |
| 0.035 | 0.297 | 0.162 | AMP-activated protein kinase stimulant | 0.162 0.021 DBMET01013 | DBMET01013 | |
| 0.013 | 0.293 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.022 DBMET01013 | DBMET01013 | |
| 0.116 | 0.409 | 0.364 | Interleukin 2 agonist | 0.364 0.039 DBMET01013 | DBMET01013 | |
| 0.048 | 0.356 | 0.343 | Immunostimulant | 0.343 0.066 DBMET01013 | DBMET01013 | |
| 0.049 | 0.392 | 0.182 | Hexokinase inhibitor | 0.182 0.048 DBMET01013 | DBMET01013 | |
| 0.051 | 0.396 | 0.133 | Interleukin 6 antagonist | 0.133 0.119 DBMET01013 | DBMET01013 | |
| 0.069 | 0.439 | 0.289 | Antithrombotic | 0.289 0.096 DBMET01013 | DBMET01013 | |
| 0.052 | 0.427 | 0.136 | DNA repair enzyme inhibitor | 0.136 0.047 DBMET01013 | DBMET01013 | |
| 0.058 | 0.438 | 0.217 | DNA synthesis inhibitor | 0.217 0.098 DBMET01013 | DBMET01013 | |
| 0.033 | 0.418 | 0.498 | Angiogenesis stimulant | 0.498 0.012 DBMET01013 | DBMET01013 | |
| 0.004 | 0.402 | 0.031 | Sodium/glucose cotransporter 2 inhibitor | 0.031 0.012 DBMET01013 | DBMET01013 | |
| 0.055 | 0.463 | 0.308 | Immunosuppressant | 0.308 0.11 DBMET01013 | DBMET01013 | |
| 0.005 | 0.413 | 0.029 | Sodium/glucose cotransporter inhibitor | 0.029 0.012 DBMET01013 | DBMET01013 | |
| 0.008 | 0.42 | 0.286 | Selectin antagonist | 0.286 0.006 DBMET01013 | DBMET01013 | |
| 0.015 | 0.427 | 0.071 | Topoisomerase II alpha inhibitor | 0.071 0.06 DBMET01013 | DBMET01013 | |
| 0.005 | 0.421 | 0.087 | Antineoplastic antibiotic | 0.087 0.053 DBMET01013 | DBMET01013 | |
| 0.083 | 0.526 | 0.64 | Cyclophilin D inhibitor | 0.64 0.021 DBMET01013 | DBMET01013 | |
| 0.011 | 0.457 | 0.071 | Protein 50S ribosomal subunit inhibitor | 0.071 0.023 DBMET01013 | DBMET01013 | |
| 0.028 | 0.48 | 0.097 | DNA polymerase I inhibitor | 0.097 0.089 DBMET01013 | DBMET01013 | |
| 0.021 | 0.482 | 0.193 | Thrombolytic | 0.193 0.055 DBMET01013 | DBMET01013 | |
| 0.014 | 0.5 | 0.092 | Topoisomerase I inhibitor | 0.092 0.077 DBMET01013 | DBMET01013 | |
| 0.022 | 0.575 | 0.135 | Cell adhesion inhibitor | 0.135 0.055 DBMET01013 | DBMET01013 | |
| 0.01 | 0.576 | 0.101 | Topoisomerase II inhibitor | 0.101 0.085 DBMET01013 | DBMET01013 | |
| 0.024 | 0.596 | 0.133 | Hemostatic | 0.133 0.092 DBMET01013 | DBMET01013 | |
| 0.015 | 0.588 | 0.062 | Factor IXa inhibitor | 0.062 0.025 DBMET01013 | DBMET01013 | |
| 0.004 | 0.579 | 0.026 | Protein 30S ribosomal subunit inhibitor | 0.026 0.015 DBMET01013 | DBMET01013 | |
| 0.01 | 0.648 | 0.059 | Antibiotic Aminoglycoside-like | 0.059 0.009 DBMET01013 | DBMET01013 | |
| 0.019 | 0.662 | 0.125 | Insulin secretagoues | 0.125 0.103 DBMET01013 | DBMET01013 | |
| 0.029 | 0.719 | 0.196 | Immunomodulator | 0.196 0.169 DBMET01013 | DBMET01013 | |
| 0.01 | 0.791 | 0.18 | Tumour necrosis factor alpha release inhibitor | 0.18 0.126 DBMET01013 | DBMET01013 | |
| 0.017 | 0.848 | 0.371 | Antiinflammatory | 0.371 0.158 DBMET01013 | DBMET01013 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |